Summary and Conclusions
- 17 Downloads
After intravenous injection, 99mTc-labelled nanocolloids are rapidly removed from the circulation by uptake in the reticuloendothelial system. During their passage at sites of inflammation, a fraction of the plasma-borne colloid dose extravasates through dehiscences of the vascular endothelium, traverses the discontinuous basement membrane and invades the basic intercellular substance, as has been demonstrated by experimental and clinical data.
Keywords99mTc DTPA Intercellular Substance Colloid Accumulation Label Leukocyte Discontinuous Basement
Unable to display preview. Download preview PDF.